Chimeric Antigen Receptor–Modified T Cells and T Cell–Engaging Bispecific Antibodies: Different Tools for the Same Job

被引：0
|
作者：
Melanie Schwerdtfeger
Mohamed-Reda Benmebarek
Stefan Endres
Marion Subklewe
Vincenzo Desiderio
Sebastian Kobold
机构：
[1] LMU Munich,Center of Integrated Protein Science Munich (CIPS
[2] University of Campania “Luigi Vanvitelli”,M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München
[3] German Center for Translational Cancer Research (DKTK),Department of Experimental Medicine
[4] German Research Center for Environmental Health (HMGU),Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München
[5] LMU Munich,Department of Medicine III, Klinikum der Universität München
来源：
Current Hematologic Malignancy Reports | 2021年 / 16卷
关键词：
Chimeric antigen receptor; Bispecific antibody; Immunotherapy; Adoptive T cell therapy; T cell redirection; Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：218 / 233
页数：15
相关论文
共 50 条
  • [1] Chimeric Antigen Receptor-Modified T Cells and T Cell-Engaging Bispecific Antibodies: Different Tools for the Same Job
    Schwerdtfeger, Melanie
    Benmebarek, Mohamed-Reda
    Endres, Stefan
    Subklewe, Marion
    Desiderio, Vincenzo
    Kobold, Sebastian
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2021, 16 (02) : 218 - 233
  • [2] Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells
    Strohl, William R.
    Naso, Michael
    ANTIBODIES, 2019, 8 (03)
  • [3] A new era in myeloma: the advent of chimeric antigen receptor-T (CAR-T) cells and bispecific antibodies
    Ho, P. Joy
    Li, Eric W.
    INTERNAL MEDICINE JOURNAL, 2025,
  • [4] T Cell Engaging Immunotherapies, Highlighting Chimeric Antigen Receptor (CAR) T Cell Therapy
    De Bousser, Elien
    Callewaert, Nico
    Festjens, Nele
    CANCERS, 2021, 13 (23)
  • [5] Cancer T Cell Immunotherapy with Bispecific Antibodies and Chimeric Antigen Receptors
    Lacher, Markus D.
    Provenzano, Maurizio
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2013, 8 (03) : 239 - 254
  • [6] Pharmacology of Chimeric Antigen Receptor-Modified T Cells
    Song, Edward Z.
    Milone, Michael C.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021, 2021, 61 : 805 - 829
  • [7] Recent advances in tumor associated carbohydrate antigen based chimeric antigen receptor T cells and bispecific antibodies for anti-cancer immunotherapy
    Rashidijahanabad, Zahra
    Huang, Xuefei
    SEMINARS IN IMMUNOLOGY, 2020, 47
  • [8] Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology
    Suzuki, Maya
    Curran, Kevin J.
    Cheung, Nai-Kong V.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (08) : 1326 - 1336
  • [9] Chimeric antigen receptor T cells: power tools to wipe out leukemia and lymphoma
    Riet, Tobias
    Abken, Hinrich
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (04) : 383 - 385
  • [10] SOHO State of the Art Updates and Next Questions: T-Cell-Directed Immune Therapies for Multiple Myeloma: Chimeric Antigen Receptor-Modified T Cells and Bispecific T-Cell-Engaging Agents
    Madduri, Deepu
    Dhodapkar, Madhav, V
    Lonial, Saar
    Jagannath, Sunday
    Cho, Hearn Jay
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (09) : 537 - 544
12345